T-cell-rich large B-cell lymphoma in children and adolescents

Abstract

BACKGROUND T‐cell–rich large B‐cell lymphoma (TCRLBCL) is a morphologic subset of diffuse large B‐cell lymphoma that has been confused with Hodgkin disease and reactive lymphadenopathies. To the authors' knowledge the majority of reports of TCRLBCL are from adults, and it is not widely recognized as occurring in the pediatric population. The current study reports a cohort of six cases of TCRLBCL from the Children's Cancer Group CCG‐5961 study. METHODS Biopsies from patients entered on CCG‐5961 were submitted for central pathology review and immunophenotyping. Six cases of TCRLBCL were identified and correlated with clinical characteristics. RESULTS Of 86 cases centrally reviewed to date on CCG‐5961, 20 (23%) were diagnosed as diffuse large B‐cell lymphomas. Of these, 6 cases (7% of total cases and 30% of large B‐cell cases) were TCRLBCL, based on a diffuse growth pattern with a minor population of neoplastic large B cells and an associated extensive reactive T‐cell infiltrate. All patients with TCRLBCL were males ages 12–16 years. Three patients with TCRLBCL had advanced stage disease. No bone marrow or central nervous system involvement was detected in any case. CONCLUSIONS TCRLBCL is a morphologic subtype of diffuse large B‐cell lymphoma that may be difficult to recognize due to the extensive infiltrate of reactive T cells. This entity is not well recognized in pediatric patients, but in the current study represented 7% of all cases and 30% of large B‐cell lymphomas received for central review from the ongoing CCG‐5961 protocol. Because TCRLBCL may be confused with Hodgkin disease and reactive lymphadenopathies, it is essential that this entity be recognized in the pediatric age group. Cancer 2000;88:2378–86. © 2000 American Cancer Society.